抗白念珠菌生物被膜药物的研究进展

摘要/Abstract

摘要： 白念珠菌是临床最常见的一种能产生生物被膜的致病真菌,所产生的生物被膜是导致高度耐药性和临床白念珠菌反复感染的直接原因。近年来,科学家们开始关注天然产物的抗生物被膜活性,以及不同药物联合应用的抗生物被膜效果,该文对抗白念珠菌生物被膜药物的研究进展作一综述。

关键词: 生物被膜, 白念珠菌, 抗真菌药物

Abstract: Candida albicans is the most common fungal pathogen which can form biofilm, and the formation of biofilm leads to drug resistance and repeated infections in clinic. Over recent years we have witnessed the discovery of natural products with anti-biofilm activity and the development of combination-therapy against Candida biofilm. The antifungal agents with anti-biofilm activity were discussed in this review.

Key words: Candida albicans, biofilm, antifungal

中图分类号:

R379.4

赵兰雪, 李德东, 王彦, 姜远英. 抗白念珠菌生物被膜药物的研究进展[J]. 中国真菌学杂志, 2013, 8(2): 124-128.

ZHAO Lan-xue, LI De-dong, WANG Yan, JIANG Yuan-ying. An update of antifungals functioning on inhibiting Candida albicans biofilm formation[J]. Chinese Journal of Mycology, 2013, 8(2): 124-128.

参考文献

[1] Azie N, Neofytos D, M, et al. The PATH (Prospective Antifungal Therapy) All iance^® registry and invasive fungal infections: update 2012. Diagnostic Microbiology and Infectious Disease. 2012, 73(4):293-300.
[2] Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance[J]. Journal of bacteriology, 2001, 183(18):5385-5394.
[3] Tobudic S, Lassnigg A, Kratzer C, et al. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases[J]. Mycoses, 2010, 53(3):208-214.
[4] Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins[J]. Antimicrobial agents and chemotherapy, 2002, 46(6):1773-1780.
[5] Ramage G, Jose A, Coco B, et al. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro[J]. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2011, 111(4): 456-460.
[6] Donlan RM and Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms[J]. Clinical microbiology reviews, 2002, 15(2):167-193.
[7] Perumal P, Mekala S and Chaffin WLJ. Role for cell density in antifungal drug resistance in Candida albicans biofilms[J]. Antimicrobial agents and chemotherapy, 2007, 51(7):2454-2463.
[8] Silva S, Pires P, Monteiro DR, et al. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic[J]. Medical Mycology, 2013, 51(2):178-184.
[9] Soustre J, Rodier MH, Imbert-Bouyer S, et al. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins[J]. Journal of Antimicrobial Chemotherapy, 2004, 53(3):522-525.
[10] Bachmann SP, VandeWK, Ramage G, et al. In vitro activity of caspofungin against Candida albicans biofilms[J]. Antimicrobial agents and chemotherapy, 2002, 46(11):3591-3596.
[11] Andriole V.T. Current and future antifungal therapy: new targets for antifungal therapy[J]. International journal of antimicrobial agents, 2000, 16(3):317-321.
[12] Cateau E, Rodier MH and Imbert C. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth[J]. Journal of Antimicrobial Chemotherapy, 2008, 62(1):153-155.
[13] Vediyappan G, Rossignol T and d'Enfert C. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans[J]. Antimicrobial agents and chemotherapy, 2010, 54(5):2096-2111.
[14] Hawser SP and Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro[J]. Antimicrobial agents and chemotherapy, 1995, 39(9):2128-2131.
[15] Sanglard D, Kuchler K, Ischer F, et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters[J]. Antimicrobial agents and chemotherapy, 1995, 39(11):2378-2386.
[16] Katragkou Α, Chatzimoschou A, Simitsopoulou M, et al. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms[J]. Antimicrobial agents and chemotherapy, 2008, 52(1):357-360.
[17] Cao YY, Dai BD, Wang Y, et al. In vitro activity of baicalein against Candida albicans biofilms[J]. International journal of antimicrobial agents, 2008, 32(1):73-77.
[18] Messier C and Grenier D. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans[J]. Mycoses, 2011, 54(6):e801-e806.
[19] 汪长中,程惠娟,官妍,等. 苦参碱对体外白念珠菌生物膜抑制作用[J]. 中国公共卫生, 2008, 12(12):1491-1492.
[20] 汪长中,程惠娟,官妍, 等. 黄连解毒汤对体外白念珠菌生物膜形成的影响[J]. 热带病与寄生虫学, 2007, 5(2):82-84.
[21] Rukayadi Y, Han S, Yong D, et al. In vitro activity of xanthorrhizol against Candida glabrata,C.guilliermondii,and C.parapsilosis biofilms[J]. Medical Mycology, 2011, 49(1):1-9.
[22] Braga PC, Culici M, Alfieri M, et al. Thymol inhibits Candida albicans biofilm formation and mature biofilm[J]. International journal of antimicrobial agents, 2008, 31(5):472-477.
[23] Dalleau S, Cateau E, Bergès T, et al. In vitro activity of terpenes against Candida biofilms[J]. International journal of antimicrobial agents, 2008, 31(6):572-576.
[24] Taweechaisupapong S, Singhara S, Lertsatitthanakorn P, et al. Antimicrobial effects of Boesenbergia pandurata and Piper sarmentosum leaf extracts on planktonic cells and biofilm of oral pathogens[J]. Pak. J. Pharm. Sci, 2010, 23(2):224-231.
[25] Thaweboon S and Thaweboon B. In vitro antimicrobial activity of Ocimum americanum L. essential oil against oral microorganisms[J]. Southeast Asian Journal of Tropical Medicine and Public Health, 2009, 40(5):1025.
[26] Sudjana AN, Carson CF, Carson KC, et al. Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil[J]. Medical Mycology, 2012,50(8):1-8.
[27] Hendry ER, Worthington T, Conway BR, et al. Antimicrobial efficacy of eucalyptus oil and 1, 8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures[J]. Journal of Antimicrobial Chemotherapy, 2009, 64(6):1219-1225.
[28] Rabea EI, Badawy MET, Stevens CV, et al. Chitosan as antimicrobial agent: applications and mode of action[J]. Biomacromolecules, 2003, 4(6):1457-1465.
[29] Martinez LR, Mihu MR, Tar M, et al. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model[J]. Journal of Infectious Diseases, 2010, 201(9):1436-1440.
[30] Coleman JJ, Okoli I, Tegos GP, et al. Characterization of plant-derived saponin natural products against Candida albicans[J]. ACS chemical biology, 2010, 5(3):321-332.
[31] Evensen N and Braun P. The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation[J]. Canadian journal of microbiology, 2009, 55(9):1033-1039.
[32] Xie C and Lou H. Chemical constituents from the Chinese bryophytes and their reversal of fungal resistance[J]. Current Organic Chemistry, 2008, 12(8):619-628.
[33] Lu ZQ, Fan PH, Ji M, et al. Terpenoids and bisbibenzyls from Chinese liverworts Conocephalum conicum and Dumortiera hirsuta[J]. Journal of Asian natural products research, 2006, 8(1-2):187-192.
[34] Cheng A, Sun L, Wu X, et al. The inhibitory effect of a macrocyclic bisbibenzyl riccardin D on the biofilms of Candida albicans[J]. Biological and Pharmaceutical Bulletin, 2009, 32(8):1417-1421.
[35] Bachmann SP, Ramage G, Vande WK, et al. Antifungal combinations against Candida albicans biofilms in vitro[J]. Antimicrobial agents and chemotherapy, 2003, 47(11):3657-3659.
[36] Tobudic S, Kratzer C, Lassnigg A, et al. In vitro activity of antifungal combinations against Candida albicans biofilms[J]. Journal of Antimicrobial Chemotherapy, 2010, 65(2):271-274.
[37] Pai MP. Antifungal combinations against simulated Candida albicans endocardial vegetations[J]. Antimicrobial agents and chemotherapy, 2009, 53(6):2629-2631.
[38] Uppuluri P, Nett J, Heitman J, et al. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms[J]. Antimicrobial agents and chemotherapy, 2008, 52(3):1127-1132.
[39] Miceli MH, Bernardo SM and Lee SA. In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms[J]. International journal of antimicrobial agents, 2009, 34(4):326-332.
[40] Ku TSN, Palanisamy SKA and Lee SA. Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals[J]. International journal of antimicrobial agents, 2010, 36(5):441-446.
[41] Shi W, Chen Z, Chen X, et al. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents[J]. FEMS yeast research, 2010, 10(7):885-893.